Calian Group (TSE:CGY – Get Free Report) has been given a C$106.00 price target by investment analysts at Ventum Financial in a report issued on Thursday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Ventum Financial’s price target points to a potential upside of 41.11% from the stock’s current price.
Several other research firms have also recently weighed in on CGY. Ventum boosted their price objective on shares of Calian Group from C$94.00 to C$100.00 and gave the company a “buy” rating in a report on Monday, June 15th. Canadian Imperial Bank of Commerce boosted their price objective on Calian Group from C$93.00 to C$107.00 in a research report on Friday, August 14th. Canaccord Genuity Group upped their price objective on Calian Group from C$103.00 to C$105.00 and gave the stock a “buy” rating in a research note on Monday, June 29th. ATB Cormark Capital Markets increased their target price on Calian Group from C$92.50 to C$98.50 and gave the stock an “outperform” rating in a research report on Tuesday, May 19th. Finally, Royal Bank Of Canada boosted their price target on Calian Group from C$90.00 to C$105.00 and gave the stock an “outperform” rating in a report on Friday, August 14th. Nine research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of C$101.72.
View Our Latest Stock Analysis on Calian Group
Calian Group Trading Down 0.6%
Calian Group (TSE:CGY – Get Free Report) last released its earnings results on Thursday, August 13th. The company reported C$1.10 EPS for the quarter. The business had revenue of C$230.40 million for the quarter. Calian Group had a return on equity of 11.67% and a net margin of 4.41%. On average, sell-side analysts predict that Calian Group will post 4.9475219 earnings per share for the current year.
Calian Group Company Profile
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.
Featured Stories
- Five stocks we like better than Calian Group
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.
